Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00671398 · ClinicalTrials.gov registry record · Phase 3
Efficacy of Ramelteon on Transient Insomnia in Healthy Adults
A Phase 3 study, sponsored by Takeda.
- Completed
- Registry status
- Phase 3
- Development phase
- 289
- Enrollment target
NCT00671398 is a Phase 3 study that has completed, run by Takeda. The registered enrollment target is 289 participants.
The verdict
NCT00671398, a Phase 3 study, has completed, sponsored by Takeda.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 289 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of Ramelteon, once daily (QD), in healthy subjects within a sleep lab.
Interventions
- DRUG Placebo
- DRUG Ramelteon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 289 participants |
| Start Date | 2002-12 |
| Est. Completion | 2003-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00671398
The ClinicalTrials.gov registry entry for NCT00671398 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 289 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Takeda, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00671398 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00671398 about?
NCT00671398 is a clinical study titled "Efficacy of Ramelteon on Transient Insomnia in Healthy Adults". The purpose of this study is to evaluate the safety and efficacy of Ramelteon, once daily (QD), in healthy subjects within a sleep lab.
What is the current status of trial NCT00671398?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 289 participants. The study started on 2002-12. Estimated completion is 2003-05.
What interventions are being tested in trial NCT00671398?
The interventions under investigation include: Placebo (DRUG), Ramelteon (DRUG).
Who is sponsoring clinical trial NCT00671398?
This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.